Back to HomeBeta

ICD-10 Coding for Chemotherapy-Induced Anemia(D64.81, T45.1X5A)

Complete ICD-10-CM coding and documentation guide for Chemotherapy-Induced Anemia. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

CIAAnemia due to chemotherapy

Related ICD-10 Code Ranges

Complete code families applicable to Chemotherapy-Induced Anemia

D50-D64Primary Range

Nutritional anemias

This range includes codes for anemia, including those induced by chemotherapy.

Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances

Includes codes for adverse effects of drugs, such as T45.1X5A for chemotherapy.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
D64.81Anemia due to antineoplastic chemotherapyUse when anemia is directly linked to chemotherapy treatment.
  • Hemoglobin <10 g/dL
  • Recent chemotherapy administration
  • Symptoms such as fatigue requiring intervention
T45.1X5AAdverse effect of antineoplastic and immunosuppressive drugsUse alongside D64.81 to indicate adverse effects of chemotherapy.
  • Documentation of chemotherapy administration
  • Symptoms or conditions resulting from chemotherapy

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for chemotherapy-induced anemia

Essential facts and insights about Chemotherapy-Induced Anemia

The ICD-10 code for chemotherapy-induced anemia is D64.81, used when anemia is directly linked to chemotherapy treatment.

Primary ICD-10-CM Codes for chemo induced anemia

Anemia due to antineoplastic chemotherapy
Billable Code

Decision Criteria

clinical Criteria

  • Anemia symptoms and lab values post-chemotherapy

documentation Criteria

  • Explicit mention of chemotherapy as the cause of anemia

Applicable To

  • Anemia caused by chemotherapy treatment

Excludes

  • Anemia due to malignancy itself (D63.0)

Clinical Validation Requirements

  • Hemoglobin <10 g/dL
  • Recent chemotherapy administration
  • Symptoms such as fatigue requiring intervention

Code-Specific Risks

  • Incorrect sequencing if not listed as primary when anemia is the focus of care.

Coding Notes

  • Ensure documentation explicitly links anemia to chemotherapy.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Adverse effect of antineoplastic and immunosuppressive drugs

T45.1X5A
Use to indicate the adverse effect of chemotherapy drugs.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Anemia in neoplastic disease

D63.0
Use D63.0 if anemia is due to the malignancy itself, not the treatment.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Chemotherapy-Induced Anemia to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D64.81.

Impact

Clinical: Incomplete clinical picture of treatment effects., Regulatory: Non-compliance with coding standards., Financial: Potential loss of reimbursement for adverse effects.

Mitigation Strategy

Always include T45.1X5A with D64.81., Review documentation for adverse effects.

Impact

Reimbursement: May affect DRG assignment and reimbursement levels., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.

Mitigation Strategy

Ensure D64.81 is listed first when anemia is the primary focus of care.

Impact

Failure to document the link between anemia and chemotherapy.

Mitigation Strategy

Implement documentation templates that require causality statements.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Chemotherapy-Induced Anemia, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Chemotherapy-Induced Anemia

Use these documentation templates to ensure complete and accurate documentation for Chemotherapy-Induced Anemia. These templates include all required elements for proper coding and billing.

Oncology follow-up for chemotherapy-induced anemia

Specialty: Oncology

Required Elements

  • Patient symptoms
  • Recent chemotherapy details
  • Hemoglobin levels
  • Treatment plan

Example Documentation

**Subjective**: 'Increased fatigue post-cycle 3 cisplatin.' **Objective**: Hb 8.2 g/dL. **Assessment**: 'Chemotherapy-induced anemia.' **Plan**: 'Start ESA therapy.'

Examples: Poor vs. Good Documentation

Poor Documentation Example
Anemia noted.
Good Documentation Example
Anemia secondary to chemotherapy cycle 3.
Explanation
The good example specifies the cause of anemia, linking it to chemotherapy.

Need help with ICD-10 coding for Chemotherapy-Induced Anemia? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more